Matinas biopharma demonstrates in vivo biological activity and disease improvement in two inflammatory disease models with oral lnc-delivered small oligonucleotides

In an acute colitis model, data show statistically significant knockdown of elevated levels of serum tnfΑ, reductions in tissue tnfΑ mrna and improvement in disease activity scores
MTNB Ratings Summary
MTNB Quant Ranking